Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Doximity Inc

Healthcare US DOCS

20.59USD
-0.11(0.53%)

Last update at 2026-06-05T20:15:00Z

Day Range

20.3821.14
LowHigh

52 Week Range

20.5576.51
LowHigh

Fundamentals

  • Previous Close 20.70
  • Market Cap4546.75M
  • Volume2403450
  • P/E Ratio20.29
  • Dividend Yield-%
  • EBITDA245.46M
  • Revenue TTM637.78M
  • Revenue Per Share TTM3.40
  • Gross Profit TTM 572.39M
  • Diluted EPS TTM1.19

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax 263.57M 185.20M 133.16M 114.00M 57.77M
Minority interest - - - - -
Net income 223.19M 147.58M 112.82M 154.78M 50.21M
Selling general administrative 45.67M 37.83M 36.74M 35.75M 16.49M
Selling and marketing expenses 145.71M 133.13M 123.52M 92.13M 62.03M
Gross profit 514.52M 424.75M 365.56M 303.76M 175.70M
Reconciled depreciation 10.66M 10.27M 10.28M 5.04M 3.70M
Ebit 230.10M 171.81M 125.11M 113.54M 53.30M
Ebitda 240.76M 182.08M 135.39M 118.58M 57.01M
Depreciation and amortization 10.66M 10.27M 10.28M 5.04M 3.70M
Non operating income net other - - - - -
Operating income 227.80M 163.88M 125.11M 113.54M 53.30M
Other operating expenses 342.60M 311.54M 293.94M 230.01M 153.59M
Interest expense - - 8.05M 0.47M 4.47M
Tax provision 40.39M 37.62M 20.34M -40.77800M 7.56M
Interest income 35.85M 21.66M - - 0.30M
Net interest income 35.85M 21.66M - - 0.30M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 40.39M 37.62M 20.34M -40.77800M 7.56M
Total revenue 570.40M 475.42M 419.05M 343.55M 206.90M
Total operating expenses 286.73M 260.88M 240.45M 190.22M 122.40M
Cost of revenue 55.87M 50.67M 53.49M 39.79M 31.20M
Total other income expense net 35.77M 21.32M 8.05M 0.47M 4.47M
Discontinued operations - - - - -
Net income from continuing ops 223.19M 147.58M 112.82M 154.78M 50.21M
Net income applicable to common shares - - 112.82M 176.31M 21.56M
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 1264.31M 1079.37M 1136.89M 991.36M 251.72M
Intangible assets 23.07M 27.32M 31.84M 7.91M 9.60M
Earning assets - - - - -
Other current assets 44.60M 48.71M 22.29M 24.95M 10.69M
Total liab 181.68M 177.98M 170.77M 112.76M 184.98M
Total stockholder equity 1082.62M 901.40M 966.12M 878.59M 66.74M
Deferred long term liab - - - - -
Other current liab 37.05M 29.68M 31.25M 25.27M 16.29M
Common stock 0.19M 0.19M 0.19M 0.19M 0.08M
Capital stock 0.19M 0.19M 0.19M 0.19M 0.08M
Retained earnings 186.89M 79.99M 217.85M 191.11M 36.32M
Other liab - - 17.38M 1.03M 1.19M
Good will 67.94M 67.94M 67.94M 18.91M 18.91M
Other assets - - - 50.82M 4.87M
Cash 209.61M 96.78M 158.03M 112.81M 66.39M
Cash and equivalents - - - - -
Total current liabilities 156.26M 147.25M 139.51M 111.28M 102.04M
Current deferred revenue 114.28M 99.14M 105.24M 84.91M 83.27M
Net debt -197.21800M -82.23900M -142.39000M -111.72000M -65.13900M
Short term debt 2.21M 2.15M 1.75M 0.64M 0.97M
Short long term debt - - - - -
Short long term debt total 12.40M 14.55M 15.64M 1.09M 1.25M
Other stockholder equity 894.23M 823.88M 762.15M -288.76800M 30.36M
Property plant equipment - - 25.10M 9.57M 8.94M
Total current assets 1088.62M 912.94M 975.45M 904.14M 209.40M
Long term investments - - - - -
Net tangible assets - - - 851.77M 38.23M
Short term investments 706.05M 666.12M 682.97M 685.30M 76.14M
Net receivables 128.35M 101.33M 107.05M 81.07M 50.32M
Long term debt - - - - -
Inventory - -42.60900M 5.12M - 5.86M
Accounts payable 1.36M 2.25M 1.27M 0.46M 1.51M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.32M -2.66400M -14.08300M -15.29400M -0.02100M
Additional paid in capital - - - - -
Common stock total equity - - - - 0.08M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.12M 1.46M 1.65M 2.26M 2.76M
Deferred long term asset charges - - - - -
Non current assets total 175.69M 166.43M 161.44M 87.22M 42.32M
Capital lease obligations 12.40M 14.55M 15.64M 1.09M 1.25M
Long term debt total - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -29.29800M 31.19M -59.92300M -635.47200M -38.34300M
Change to liabilities - - 17.53M 10.49M 38.66M
Total cashflows from investing activities -29.29800M 31.19M -59.92300M -640.57400M -70.41700M
Net borrowings - - - - -
Total cash from financing activities -131.13800M -276.52400M -74.46100M 560.41M 5.41M
Change to operating activities - - -12.12300M -19.80500M -8.17800M
Net income 223.19M 147.58M 112.82M 154.78M 50.21M
Change in cash 112.83M -61.24200M 45.22M 46.42M 17.96M
Begin period cash flow 96.78M 158.03M 112.81M 66.39M 48.43M
End period cash flow 209.61M 96.78M 158.03M 112.81M 66.39M
Total cash from operating activities 273.26M 184.10M 179.60M 126.58M 82.97M
Issuance of capital stock - 0.00000M 0.00000M 553.90M -
Depreciation 10.66M 10.27M 10.28M 5.04M 3.70M
Other cashflows from investing activities -6.52500M -5.65400M - 0.59M -0.01200M
Dividends paid - - - - -
Change to inventory - - - - 1.21M
Change to account receivables -27.20600M 3.99M -26.24200M -31.01700M -20.45200M
Sale purchase of stock -120.29300M -280.71600M -85.32400M -2.69800M -2.02200M
Other cashflows from financing activities -34.14600M 4.19M 10.86M 9.21M 7.43M
Change to netincome - - - -2.67300M 12.14M
Capital expenditures 6.53M 5.80M 6.18M 5.70M 4.61M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -24.09700M -24.52400M -21.03300M -40.33000M 10.03M
Stock based compensation 72.39M 51.08M 47.83M 31.44M 7.25M
Other non cash items 2.72M 8.29M 16.47M 16.89M 6.79M
Free cash flow 266.74M 178.29M 173.42M 120.88M 78.36M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DOCS
Doximity Inc		 -0.11 0.53% 20.59 20.29 15.43 7.13 4.60 5.93 15.01
VEEV
Veeva Systems Inc Class A		 -5.99 3.35% 172.61 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 8.55 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 0.08 1.68% 4.84 31.84 26.25 0.05 4.60 0.04 0.12
BTSG
BrightSpring Health Services, Inc. Common Stock		 - -% 57.40 100.22 40.65 0.69 4.92 0.92 25.80

Reports Covered

Stock Research & News

View All

Profile

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Doximity Inc

500 3rd Street, San Francisco, CA, United States, 94107

Key Executives

Name Title Year Born
Mr. Jeffrey A. Tangney Co-Founder, CEO & Chairperson 1973
Ms. Anna Bryson Chief Financial Officer 1990
Mr. Paul Jorgensen Chief Revenue Officer 1970
Dr. Nate Gross M.D. Co-Founder & Chief Strategy Officer NA
Ms. Shari Buck Co-founder and SVP People & Ops NA
Mr. Jey Balachandran Chief Technology Officer NA
Mr. Perry Scott Gold Head of Investor Relations NA
Ms. Jennifer W. Chaloemtiarana Gen. Counsel & Corp. Sec. 1968
Jim Rivas Head of Corp. Communications NA
Mr. Bruno Miranda Sr. VP of Engineering NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.